Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Highlights of Merck’s Q4 2023 financial results
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of 2023, despite a modest increase in revenues.
Fourth-quarter worldwide sales increased 6% year-over-year to $14.6 billion, mainly reflecting the sustained growth across oncology and vaccines.
The company reported a net loss of $1.23 billion or $0.48 per share for the December quarter, compared to a profit of $3.02 billion or $1.18 per share in the prior-year period. On an adjusted basis, it was earnings of $0.03 per share in Q4, down 98% from the fourth quarter of 2022.
“As we move forward, I’m confident that our strong momentum will continue, underpinned by the unwavering dedication of our talented global team,” said Merck’s CEO Robert Davis.
Prior Performance
Most Popular
Key highlights from Hewlett Packard Enterprise’s (HPE) Q1 2025 earnings results
Hewlett Packard Enterprise (NYSE: HPE) reported its first quarter 2025 earnings results today. Revenue was $7.9 billion, up 16% year-over-year and 17% in constant currency. Net earnings attributable to common
AVGO Infographic: Broadcom Q1 2025 revenue and earnings beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenue and adjusted earnings for the first quarter of 2025. The numbers also surpassed Wall Street's expectations. Earnings, excluding special items, increased
Macy’s (M) Q4 2024 Earnings: Key financials and quarterly highlights
Macy’s Inc. (NYSE: M) reported its fourth quarter 2024 earnings results today. Net sales decreased 4.3% year-over-year to $7.8 billion. Comparable sales were down 1.1% on an owned basis and
